Renewable energy solutions provider Ezon Energy has raised INR 140 crore from Japanese investor Natori Nohisa to set up 140 MW of solar power projects in Karnataka and Kerala. The funding has been structured on equity and project basis, thus avoiding stake dilution in Ezon Energy.
Agritech-focused Omnivore Partners is investing in Chennai-based FR8, a tech startup which develops solutions for the long-haul trucking segment. The funding will be utilized for expansion, technology and talent.
Healofy, a peer-to-peer content platform of moms and moms-to-be, has been selected for Facebook’s FbStart programme and will get upto $40,000 credits and free tools and services from Facebook and its more than 30 partners including Amazon, UserTesting, Dropbox, and MailChimp. Founded in October, Bangalore-based Healofy attracts women around health and lifestyle in the form of user generated content and Q/As on pregnancy and parenting.
Bengaluru-based relocation service provider Pikkol has received seed funding from a group of angel investors, including Ajay Nanavati, former chairman of 3M India, the Indian arm of US multinational conglomerate 3M Co and Afsal Salu, co-founder of hyperlocal delivery company Delyver. Pikkol, run by Rednile Innovations Pvt Ltd, operates as a relocation service platform where customers can search for a tailor-made solution for their relocation needs. The startup makes use of analytics-based technological backend and logistics network for servicing the orders.
Bengaluru-based health-tech startup Idea Bubbles Consulting Services Pvt Ltd has raised $700K from early stage funding platform 1Crowd, health and hygiene firm Eureka Forbes Ltd, along with its parent Shapoorji Pallonji & Co Pvt Ltd. Founded in 2014 the startuo has developed ‘Eureka Forbes Good Health’ (EFGH) platform that enables doctors to offer patients tele-consultation services underpinned with several offerings such as digitised medical records. Its twin platform, ‘HappiDoc’, works with EFGH by providing doctors a curated stream of medical research and case articles, while also facilitating market research for pharma companies and sponsored continuous medical education (CME) programmes.